Immuse
  • English
    • English
    • Chinese
    • IMMUSE LC-Plasma for Taiwan
For Manufacturers
Menu
Contact
  • English
    • English
    • Chinese
    • IMMUSE LC-Plasma for Taiwan
For Manufacturers
  • About IMMUSE®
    • Immune System 101
    • What is a Postbiotic?
    • Consumer FAQs
  • Benefits
    • Immune Support
    • Sports Nutrition Support
    • Productivity Support
  • Science & Research
    • Vital Role of pDCs
  • Where to Find
  • News & Blog
    • Blog
  • Contact Us

IMMUSE® News

  • Kyowa Hakko Announces the Results of Three New Consumer Surveys on Consumer Preferences

    15 December 2021 PRWeb.com

    New consumer surveys reveal supplement users prefer branded ingredients 2x over generic ingredients when making purchasing decisions. Read More ›

  • Kyowa Hakko USA Awarded Best-In-Class Ingredient by Natural Products Insider's Ingredient Idol for its Immune Support Postbiotic, IMMUSE™

    16 November 2021

    Highlighted at the Annual Supply Side West Conference, the Function of Kyowa Hakko’s Novel Postbiotic was recognized as a leader for Immune Health. Read More ›

  • iMUSE Wins 2021 Product of the Year Award in the Immune Support Category at the Nutralngredients-Asia Awards

    30 September 2021

    Kirin Holdings Company, Limited's (Kirin Holdings) iMUSE brand (IMMUSE in some markets), won the 2021 Product of the Year Award in the Immune Support category of the Nutralngredients-Asia Awards, held by William Reed Business Media (WRBM), a leading publisher of digital newsletters, publications and data sources for the food, beverage and nutrition industries worldwide. Read More ›

  • Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™

    21 September 2021

    The solution offers superior ease of formulation, potential application versatility, and more comprehensive immune support compared to probiotics and other immune health ingredients. Read More ›

  • Kirin Holdings to Double Lactococcus Lactis Strain Plasma Production

    09 September 2021

    Kirin Holdings Company, Limited (Kirin Holdings) announces that it will expand manufacturing equipment at the iMUSE Health Science Factory (located in Saitama Prefecture, just north of Tokyo) - a manufacturing center for lactic acid bacteria raw material - in order to meet the increasing demand for Kirin's proprietary Lactococcus lactis strain Plasma (L. lactis strain Plasma), the functional ingredient in the popular iMUSE brand of immune maintenance products. The new manufacturing equipment is scheduled to begin operating in 2023, and will double the annual production capacity of L. lactis strain Plasma to approximately 28 tons in 2023. Read More ›

  • Performance Lab Unveils a Breakthrough Immunity Support Supplement, Featuring Two Kyowa Hakko Branded Ingredients

    13 July 2021

    PL-Immune™ features Setria® Glutathione and IMMUSE™, a new-to-market Lactococcus lactis strain Plasma (LC-Plasma), a unique paraprobiotic for more comprehensive immune support. Read More ›

  • New Research Highlighted at the International Society of Sports Nutrition Supports the Function of a Novel Kyowa Hakko Paraprobiotic for High-Intensity Training

    30 June 2021

    Kyowa Hakko showcased the latest branded ingredient innovations including IMMUSE™ Lactococcus lactis strain Plasma and EYEMUSE™ Lacticaseibacillus paracasei KW3110. Read More ›

  • Launch of the IMMUSE® brand of plasma lactic acid bacteria in Europe

    01 June 2021

    Kyowa Hakko Europe started sales promotion of Lactococcus lactis strain Plasma under the IMMUSE® brand in the European market on 20 April 2021. Lactococcus lactis strain Plasma is now available as an added-value health ingredient that can easily be added to foods, drinks or supplements made from European companies. Read More ›

  • Kyowa Hakko Announces "IMMUSE™ LC-Plasma: A Unique Approach to Immune Health" Live Webinar

    06 October 2020

    Leading international health ingredient manufacturer Kyowa Hakko is excited to announce an interactive webinar will be held on Wednesday, October 7th at 2:00pm EDT with Natural Products Insider to discuss, and educate, on the newest approach that supports the immune system. Read More ›

  • The Latest Breakthrough Approach in Immunity – IMMUSE™ Enters the U.S. Market

    28 September 2020 New York, NY, USA

    International health ingredient manufacturer Kyowa Hakko Bio Co., Ltd. and parent company Kirin Holdings Co., Ltd. announce the launch of its novel dietary supplement ingredient IMMUSE™, delivering a new approach for broad range immune support. Read More ›

  • ← Prev
  • 1
  • 2

Interested in IMMUSE? Subscribe to updates.

Subscribe to updates Subscribe for updates
Find Products
Find Products Find products that contain IMMUSE
Find Products Find products that contain IMMUSE
Kirin logo      Kyowa logo
Home | Get News Alerts | News | Where to Find | Privacy Policy | Kyowa Hakko USA | Kyowa Hakko Bio | Kirin Holdings | Contact Us | Kyowa Partner Toolkit

IMMUSE® is a clinically researched lactic acid bacteria developed by Kirin Holdings Co., Ltd.

Copyright © 2010-2025 by All Rights Reserved.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.